Research and development and clinical effect evaluation of antiSARS-CoV-2 new nucleoside drugs
- Funded by BRICS
- Total publications:0 publications
Grant number: 071 - RDCEEA-SC-2NND
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
BRICSPrincipal Investigator
Renato Martins da Silva, Mariia Sergeeva, Jijie ChaiResearch Location
Brazil, Russia, ChinaLead Research Institution
Galzu Institute for Research, Research Institute of Influenza, Tsinghua UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable